The role of arachidonic acid regulatory enzymes in colorectal disease

Diseases of the Colon and Rectum

Volumn 48, Issue 7, 2005, Pages 1471-1483

  Abir, Farshad ^a   Alva, Suraj ^a   Kaminski, Donald L ^a   Longo, Walter E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arachidonic acid; Chemoprevention; Colorectal cancer; Inflammatory bowel disease; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; FOLIC ACID; LEUKOTRIENE; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPASE A2; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; SULINDAC; THROMBOCYTE ACTIVATING FACTOR;

ABDOMINAL PAIN; ANALGESIA; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLITIS; COLLAGENOUS COLITIS; COLON ADENOMA; COLON CANCER; COLORECTAL CANCER; COLORECTAL CARCINOMA; COLORECTAL DISEASE; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SELECTIVITY; DYSPEPSIA; ENTERITIS; ENZYME INHIBITION; ENZYME REGULATION; EOSINOPHIL COLITIS; FAMILIAL COLON POLYPOSIS; GASTRITIS; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE ULCER; ISCHEMIC COLITIS; LONG TERM CARE; NAUSEA; NEPHROTOXICITY; NONHUMAN; PEPTIC ULCER; PROTEIN FUNCTION; PSEUDOMEMBRANOUS COLITIS; STOMACH EROSION; STOMACH HEMORRHAGE; STOMACH PERFORATION;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; COLONIC DISEASES; COLORECTAL NEOPLASMS; CYCLOOXYGENASE INHIBITORS; ENTEROCOLITIS; HUMANS; INFLAMMATORY BOWEL DISEASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECTAL DISEASES;

EID: 21644443044     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-005-0015-y     Document Type: Article

References (133)

1. JR Vane RJ Flower RM Botting 1990 History of aspirin and its mechanism of action Stroke 21 (Suppl) IV12 23
2. HE Mulcahy D O'Donoghue 2002 Nonsteroidal anti-inflammatory drugs and their colonic effects: more interesting than irritating? Eur J Gastroenterol Hepatol 14 1177 8
3. MM Wolfe DR Lichtenstein G Singh 1999 Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs N Engl J Med 340 1888 99
4. Smale S, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. NSAIDs and relapse IBD [abstract]. Gastroenterology 2002;A23.
5. MF Byrne J McGuinness CM Smyth 2002 Nonsteroidal anti-inflammatory drug-induced diaphragms and ulceration in the colon Eur J Gastroenterol Hepatol 14 1265 9
6. GD Hooker JC Gregor TP Ponich TD McLarty 1996 Diaphragm-like strictures of the right colon induced by indomethacin suppositories: evidence of a systemic effect Gastrointest Endosc 44 199 202
7. DV Gopal RM Katon 1999 Endoscopic balloon dilation of multiple NSAID-induced colonic strictures: case report and review of literature on NSAID-related colopathy Gastrointest Endosc 50 120 3
8. JA Smith BC Pineau 2000 Endoscopic therapy of NSAID-induced colonic diaphragm disease: two cases and a review of published reports Gastrointest Endosc 52 120 5
9. I Bjarnason P Williams A So 1984 Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs Lancet 2 1171 4
10. DM Schreinemachers RB Everson 1994 Aspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 138 46
11. MJ Thun MM Namboodiri CW Heath Jr 1991 Aspirin use and reduced risk of fatal colon cancer N Engl J Med 325 1593 6
12. E Giovannucci KM Egan DJ Hunter 1995 Aspirin and the risk of colorectal cancer in women N Engl J Med 333 609 14
13. W Smalley WA Ray J Daugherty MR Griffin 1999 Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study Arch Intern Med 159 161 6
14. LA Garcia-Rodriguez C Huerta-Alvarez 2001 Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs Epidemiology 12 88 93
15. RJ Spencer LJ Melton 3rd RL Ready DM Ilstrup 1984 Treatment of small colorectal polyps: a population-based study of the risk of subsequent carcinoma Mayo Clin Proc 59 305 10
16. AT Chan 2003 Aspirin, non-steroidal anti-inflammatory drugs and colorectal neoplasia: future challenges in chemoprevention Cancer Causes Control 14 413 8
17. JA Tangrea PS Albert E Lanza 2003 Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States) Cancer Causes Control 14 403 11
18. JA Baron BF Cole RS Sandler 2003 A randomized trial of aspirin to prevent colorectal adenomas N Engl J Med 348 891 9
19. RS Sandler S Halabi JA Baron 2003 A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer N Engl J Med 348 883 90
20. Whittle BJ. Prostanoids are regulators of gastrointestinal functions. In: Johnson LR, ed. Physiology of the gastrointestinal tract. New York: Raven Press, 1987: 143
21. Burr GO. A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem 1930;86:587-621.
22. Kurzrok R. The prospects for hormonal sterilization. Proc Soc Exp Biol Med 1930;200:857-9.
23. Bergstrom H, Samuelsson B. The enzymatic formation of prostaglandin E2 from arachidonic acid prostaglandins and related factors 32. Biochem Biophys Acta 1964;90:207-10.
24. B Samuelsson 1983 Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation Science 220 568 75
25. HR Herschman W Xie S Reddy 1995 Inflammation, reproduction, cancer and all that. The regulation and role of the inducible prostaglandin synthase Bioessays 17 1031 7
26. CE Eberhart RJ Coffey A Radhika FM Giardiello S Ferrenbach RN DuBois 1994 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1183 8
27. BI Hirschowitz A Lanas 2002 Atypical and aggressive upper gastrointestinal ulceration associated with aspirin abuse J Clin Gastroenterol 34 523 8
28. L Laine S Harper T Simon 1999 A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group Gastroenterology 117 776 83
29. P Emery H Zeidler TK Kvien 1999 Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison Lancet 354 2106 11
30. SJ Shiff L Qiao LL Tsai B Rigas 1995 Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells J Clin Invest 96 491 503
31. SJ Shiff MI Koutsos L Qiao B Rigas 1996 Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis Exp Cell Res 222 179 88
32. DJ Elder DE Halton A Hague C Paraskeva 1997 Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression Clin Cancer Res 3 1679 83
33. MK Jones H Wang BM Peskar 1999 Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing Nat Med 5 1418 23
34. M Tsujii S Kawano S Tsuji H Sawaoka M Hori RN DuBois 1998 Cyclooxygenase regulates angiogenesis induced by colon cancer cells Cell 93 705 16
35. Y Rayyan J Williams B Rigas 2002 The role of NSAIDs in the prevention of colon cancer Cancer Invest 20 1002 11
36. GJ Tsioulias G Triadafilopoulos E Goldin 1993 Expression of HLA class I antigens in sporadic adenomas and histologically normal mucosa of the colon Cancer Res 53 2374 8
37. P Arvind ED Papavassiliou E Goldin MI Koutos B Rigas 1996 Aspirin and aspirin like drugs induce the expression of HLA DR in HT29 colon adenocarcinoma cells Int J Oncol 8 1207 11
38. SL Parker T Tong S Bolden PA Wingo 1996 Cancer statistics, 1996 CA Cancer J Clin 46 5 27
39. SH Landis T Murray S Bolden PA Wingo 1999 Cancer statistics, 1999 CA Cancer J Clin 49 8 31
40. H Berkel RF Holcombe M Middlebrooks K Kannan 1996 Nonsteroidal antiinflammatory drugs and colorectal cancer Epidemiol Rev 18 205 17
41. AH Tashjian Jr EF Voelkel P Goldhaber L Levine 1973 Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma Prostaglandins 3 515 24
42. A Bennett M Del Tacca 1975 Proceedings: prostaglandins in human colonic carcinoma Gut 16 409
43. M Pollard PH Luckert 1980 Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors Cancer Treat Rep 64 1323 7
44. M Pollard PH Luckert 1984 Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitro-sourea Cancer Lett 25 117 21
45. E Giovannucci 1999 The prevention of colorectal cancer by aspirin use Biomed Pharmacother 53 303 8
46. PA Janne RJ Mayer 2000 Chemoprevention of colorectal cancer N Engl J Med 342 1960 8
47. NJ Shaheen WL Straus RS Sandler 2002 Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs Cancer 94 950 63
48. SL Kargman GP O'Neill PJ Vickers JF Evans JA Mancini S Jothy 1995 Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer Cancer Res 55 2556 9
49. H Sano Y Kawahito RL Wilder 1995 Expression of cyclooxygenase-1 and -2 in human colorectal cancer Cancer Res 55 3785 9
50. RA Gupta RN Dubois 2001 Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 Nat Rev Cancer 1 11 21
51. KW Kinzler MC Nilbert LK Su 1991 Identification of FAP locus genes from chromosome 5q21 Science 253 661 5
52. D Labayle D Fischer P Vielh 1991 Sulindac causes regression of rectal polyps in familial adenomatous polyposis Gastroenterology 101 635 9
53. FM Giardiello SR Hamilton AJ Krush 1993 Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1313 6
54. G Steinbach PM Lynch RK Phillips 2000 The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 1946 52
55. WR Waddell GF Ganser EJ Cerise RW Loughry 1989 Sulindac for polyposis of the colon Am J Surg 157 175 9
56. MT Spagnesi F Tonelli P Dolara 1994 Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment Gastroenterology 106 362 6
57. Ahnen DJ. Colon cancer prevention by NSAIDs: what is the mechanism of action? Eur J Surg Suppl 1998;164:111-4
58. M Cruz-Correa LM Hylind KE Romans SV Booker FM Giardiello 2002 Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study Gastroenterology 122 641 5
59. M Oshima JE Dinchuk SL Kargman 1996 Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 803 9
60. T Kawamori CV Rao K Seibert BS Reddy 1998 Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis Cancer Res 58 409 12
61. N Svartz 1988 Sulfasalazine: II. Some notes on the discovery and development of salazopyrin Am J Gastroenterol 83 497 503
62. A Kornbluth R Gupta CD Gerson 1990 Life-threatening diarrhea after short-term misoprostol use in a patient with Crohn ileocolitis Ann Intern Med 113 474 5
63. WM O'Brien GF Bagby 1985 Rare adverse reactions to nonsteroidal antiinflammatory drugs (3) J Rheumatol 12 562 7
64. NM Davies 1995 Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine Dis Colon Rectum 38 1311 21
65. MS Phillips B Fehilly S Stewart 1983 Enteritis and colitis associated with mefenamic acid BMJ 287 1626 7
66. JM Evans AD McMahon FE Murray DG McDevitt TM MacDonald 1997 Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease Gut 40 619 22
67. JB Felder BI Korelitz R Rajapakse S Schwarz AP Horatagis G Gleim 2000 Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study Am J Gastroenterol 95 1949 54
68. SB Hanauer W Sandborn 2001 Management of Crohn's disease in adults Am J Gastroenterol 96 635 43
69. U Mahadevan EV Loftus Jr WJ Tremaine WJ Sandborn 2002 Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease Am J Gastroenterol 97 910 4
70. GF Bonner M Walczak L Kitchen M Bayona 2000 Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease Am J Gastroenterol 95 1946 8
71. JA Dominitz EJ Boyko 2000 Association between analgesic use and inflammatory bowel disease flares: a retrospective cohort study Gastroenterol 188 635 43
72. F Karmeli P Cohen D Rachmilewitz 2000 Cyclo-oxygen-ase-2 inhibitors ameliorate the severity of experimental colitis in rats Eur J Gastroenterol Hepatol 12 223 31
73. CA Lesch ER Kraus B Sanchez R Gilbertsen A Guglietta 1999 Lack of beneficial effect of COX-2 inhibitors in an experimental model of colitis Methods Find Exp Clin Pharmacol 21 99 104
74. JL Wallace 1997 Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years Gastroenterology 112 1000 16
75. II Singer DW Kawka S Schloemann T Tessner T Riehl WF Stenson 1998 Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease Gastroenterology 115 297 306
76. AJ Morris LA Wasson JF MacKenzie 1992 Small bowel enteroscopy in undiagnosed gastrointestinal blood loss Gut 33 887 9
77. BI Hirschowitz 1994 Nonsteroidal antiinflammatory drugs and the gastrointestinal tract Gastroenterologist 2 207 23
78. I Bjarnason J Hayllar AJ MacPherson AS Russell 1993 Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans Gastroenterology 104 1832 47
79. GR Gibson EB Whitacre CA Ricotti 1992 Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature Arch Intern Med 152 625 32
80. JL Wallace CM Keenan D Gale TS Shoupe 1992 Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis Gastroenterology 102 18 27
81. BK Reuter S Asfaha A Buret KA Sharkey JL Wallace 1996 Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2 J Clin Invest 98 2076 85
82. CJ Woolverton JJ White Jr RB Sartor 1989 Eicosanoid regulation of acute intestinal vascular permeability induced by intravenous peptidoglycan- polysaccharide polymers Agents Actions 26 301 9
83. JL Wallace AW Tigley 1995 Review article: new insights into prostaglandins and mucosal defense Aliment Pharmacol Ther 9 227 35
84. JL Wallace BJ Whittle NK Boughton-Smith 1985 Prostaglandin protection of rat colonic mucosa from damage induced by ethanol Dig Dis Sci 30 866 76
85. H Allgayer K Deschryver WF Stenson 1989 Treatment with 16,16-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation Gastroenterology 96 1290 300
86. JL Wallace CM Keenan 1990 An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis Am J Physiol 258 G527 34
87. E Smecuol JC Bai E Sugai 2001 Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs Gut 49 650 5
88. A Lanas P Serrano E Bajador F Esteva R Benito R Sainz 1997 Evidence of aspirin use in both upper and lower gastrointestinal perforation Gastroenterology 112 683 9
89. J Lang AB Price AJ Levi M Burke JM Gumpel I Bjarnason 1988 Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs J Clin Pathol 41 516 26
90. MC Allison AG Howatson CJ Torrance FD Lee RI Russell 1992 Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs N Engl J Med 327 749 54
91. CA Speed MG Bramble WA Corbett I Haslock 1994 Non-steroidal anti-inflammatory induced diaphragm disease of the small intestine: complexities of diagnosis and management Br J Rheumatol 33 778 80
92. CS Kaza K Kashfi B Rigas 2002 Colon cancer prevention with NO-releasing NSAIDs Prostaglandins Other Lipid Mediat 67 107 20
93. AW Bak W McKnight P Li 1998 Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma Life Sci 62 PL367 73
94. JL Williams S Borgo I Hasan E Castillo F Traganos B Rigas 2001 Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention Cancer Res 61 3285 9
95. MR Wright NM Davies F Jamali 1994 Rationale for the development of stereochemically pure enantiomers: are the R enantiomers of chiral nonsteroidal anti-inflammatory drugs inactive? J Pharm Sci 83 911 2
96. G Ara BA Teicher 1996 Cyclooxygenase and lipoxygenase inhibitors in cancer therapy Prostaglandins Leukot Essent Fatty Acids 54 3 16
97. I Shureiqi KJ Wojno JA Poore 1999 Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygen-ase-1 expression in human colon cancers Carcinogenesis 20 1985 95
98. I Shureiqi D Chen R Lotan 2000 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells Cancer Res 60 6846 50
99. S Yamashita J Yamashita M Ogawa 1994 Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency Br J Cancer 69 1166 70
100. S Yamashita M Ogawa T Abe 1994 Group II phospholipase A2 in invasive gastric cancer cell line is induced by interleukin 6 Biochem Biophys Res Commun 198 878 84
101. T Abe K Sakamoto H Kamohara Y Hirano N Kuwahara M Ogawa 1997 Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer Int J Cancer 74 245 50
102. CW Hendrickse S Radley IA Donovan MR Keighley JP Neoptolemos 1995 Activities of phospholipase A2 and diacylglycerol lipase are increased in human colorectal cancer Br J Surg 82 475 8
103. M Snoj 1995 Metastatic intraperitoneal spread is initiated by phospholipase A2 Med Hypotheses 44 392 4
104. M Murakami T Kambe S Shimbara 1999 Different functional aspects of the group II subfamily (Types IIA and V) and type X secretory phospholipase A(2)s in regulating arachidonic acid release and prostaglandin generation. Implications of cyclooxygenase-2 induction and phospholipid scramblase-mediated cellular membrane perturbation J Biol Chem 274 31435 44
105. CC Leslie 1997 Properties and regulation of cytosolic phospholipase A2 J Biol Chem 272 16709 12
106. KH Hong JC Bonventre E O'Leary JV Bonventre ES Lander 2001 Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis Proc Natl Acad Sci USA 98 3935 9
107. K Takaku M Sonoshita N Sasaki 2000 Suppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene J Biol Chem 275 34013 6
108. P Sharon M Ligumsky D Rachmilewitz U Zor 1978 Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine Gastroenterology 75 638 40
109. CJ Hawkey SC Truelove 1981 Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay Gut 22 190 3
110. CJ Hawkey M Lo Casto 1983 Inhibition of prostaglandin synthetase in human rectal mucosa Gut 24 213 7
111. CJ Hawkey F Karmeli D Rachmilewitz 1983 Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease Gut 24 881 5
112. NK Boughton-Smith CJ Hawkey BJ Whittle 1983 Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa Gut 24 1176 82
113. EA Lobos P Sharon WF Stenson 1987 Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4 Dig Dis Sci 32 1380 8
114. G Olaison R Sjodahl C Tagesson 1988 Increased phospholipase A2 activity of Ileal mucosa in Crohn's disease Digestion 41 136 41
115. G Olaison P Leandersson R Sjodahl C Tagesson 1989 Increase in permeability and phospholipase A2 activity of colonic mucosa in Crohn's colitis Digestion 43 228 33
116. Denizot Y. Handbook of experimental pharmacology: platelets and their factors. In: Von Bruchhausen F, Walter U, eds. Berlin: Springer, 1997:483-506
117. SM Prescott GA Zimmerman DM Stafforini TM McIntyre 2000 Platelet-activating factor and related lipid mediators Annu Rev Biochem 69 419 45
118. H Saito T Hayakawa H Mita K Akiyama T Shida 1992 PAF-induced eosinophilic and basophilic differentiation in human hematopoietic precursor cells J Lipid Mediat 5 135 7
119. CS Smith WT Shearer 1994 Activation of NF-kappa B and immunoglobulin expression in response to platelet-activating factor in a human B cell line Cell Immunol 155 292 303
120. LL Stoll NR Yerram AA Spector 1991 Effect of differentiation on platelet-activating factor metabolism in HL-60 cells J Cell Sci 100 145 52
121. JG Filep P Braquet T Mozes 1991 Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog Circ Shock 35 1 8
122. JV Esplugues BJ Whittle 1988 Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat Br J Pharmacol 93 222 8
123. D Rachmilewitz PL Simon LW Schwartz DE Griswold JD Fondacaro MA Wasserman 1989 Inflammatory mediators of experimental colitis in rats Gastroenterology 97 326 37
124. LE LeDuc KC Su E Guth T Reedy PH Guth 1993 Effects of cyclooxygenase and lipoxygenase inhibition on eicosanoids and healing of acetic acid colitis in rats Dig Dis Sci 38 289 94
125. K Sperber J Shim M Mehra 1998 Mucin secretion in inflammatory bowel disease: comparison of a macrophage-derived mucin secretagogue (MMS-68) to conventional secretagogues Inflamm Bowel Dis 4 12 7
126. H Wang S Chakrabarty 2003 Platelet-activating factor activates mitogen-activated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells Oncogene 22 2186 91
127. Tagesson C, Otamiri T. BN 52021 ameliorates mucosal damage associated with small intestinal ischemia in rats. In: Ginkgolides PB, ed. Chemistry, biology, pharmacology and clinical science. Barcelona: Prous Science Publishers, 1988:553-61
128. JL Wallace G Steel BJ Whittle V Lagente B Vargaftig 1987 Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists Gastroenterology 93 765 73
129. AC Rosam JL Wallace BJ Whittle 1986 Potent ulcerogenic actions of platelet-activating factor on the stomach Nature 319 54 6
130. R Eliakim F Karmeli E Razin D Rachmilewitz 1988 Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone Gastroenterology 95 1167 72
131. Rachmilewitz D, Eliakim R, Simon P, Ligumsky M, Karmeli F. Cytokines and platelet-activating factor in human inflamed colonic mucosa. Agents Actions 1992;Spec No:C32-6
132. I Sobhani S Hochlaf Y Denizot 1992 Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients Gut 33 1220 5
133. TK Asano RS McLeod 2004 Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review Dis Colon Rectum 47 665 73